Clinical trial · Observational
Implementation of Precision Medicine in High-risk Prostate Cancer
Swedish Prostate Cancer Initiative for Novel Treatment Regimens - Real, Implementation of Precision Medicine in High-risk Prostate Cancer
NCT06687421CI-TRIAL-00094412SPRINTR-REALrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This project's objective is to initiate a prospective non-interventional clinical study to perform full molecular characterization and subtyping of the primary tumor prostate cancer patients. It will identify, compare, and select biomarkers for treatment response in high-risk/metastatic prostate cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Active monitoring | Other | — | UNRESOLVED |
| Androgen deprivation therapy | Drug | — | UNRESOLVED |
| High-risk treatment SOC | Other | — | UNRESOLVED |
| Radical prostatectomy | Procedure | — | UNRESOLVED |
| Radiotherapy | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- label
- Non-metastatic high-risk prostate cancer
- description
- ISUP ≥4, T3-4, or regional lymph node positive
- interventionNames
- Other: High-risk treatment SOC
- label
- Low risk prostate cancer
- description
- ISUP = 1, PSA \<10 µg/L, PSA-density \<0,15 µg/l/cm3
- interventionNames
- Other: Active monitoring
- label
- Medium risk prostate cancer
- description
- ISUP 2-3, PSA 10-20 µg/L
- interventionNames
- Procedure: Radical prostatectomy
- Radiation: Radiotherapy
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Men investigated for suspected prostate cancer * Signed consent form Exclusion Criteria: * Difficulties understanding information about the study due to linguistic, cognitive or other reason
References
Publications (0)
Data not yet available
No reference posted for this study.